Search results

Advertisers use online customer data to target their marketing appeals. This has heightened consumers' privacy concerns, leading governments to pass laws designed to protect consumer privacy by restricting the use of data and by restricting online tracking techniques used by websites. We use the responses of 3.3 million survey takers who had been randomly exposed to 9,596 online display (banner) advertising campaigns to explore how privacy regulation in the European Union (EU) has influenced advertising effectiveness. This privacy regulation restricted advertisers' ability to collect data on Web users in order to target ad campaigns. We find that, on average, display advertising became far less effective at changing stated purchase intent after the EU laws were enacted, relative to display advertising in other countries. The loss in effectiveness was more pronounced for websites that had general content (such as news sites), where non-data-driven targeting is particularly hard to do. The loss of effectiveness was also more pronounced for ads with a smaller presence on the webpage and for ads that did not have additional interactive, video, or audio features.

The contrasting interaction potentials of commonly used seating ar rangements for small and large group meetings are discussed from the vantage point of contemporary definitions of privacy, which define pri vacy as the right individuals have to control what information about themselves should or should not be communicated to others and under what circumstances. Privacy is further defined as a functional aspect of the design of physical environments. Research is reviewed to show that seat location is associated with verbal interaction rates and visual acces sibility among and between group members and leaders. Furthermore, it is argued that group members' seating choices may be manifestations of coping behavior and privacy regulation and that it might be appropriate, therefore, to design and test seating layouts that allow individual users self-selected options for involvement or withdrawal. A seating arrange ment that provides these options is suggested along with some pos sibilities for enhancing privacy regulation by individuals. The paper concludes with the suggestion that user-initiated interventions into the design of physical environments can follow awareness of the dynamics of these environments.

AbstractDespite a rich body of literature on politicisation, knowledge of this process and its driving forces remains limited. Specifically, little empirical analysis has been carried out to assess the impact of focusing events on politicisation within global and seemingly technical venues of policy‐making. Building on existing studies, I conceptualise politicisation as a combination of three components: (1) issue salience, (2) actor expansion and (3) actor diversity. I test the impact of focusing events on the politicisation of one of the most pressing global policy issues of our age: internet regulation, specifically regarding global data protection and internet privacy rules. I use a systematic analysis of news media coverage over a 20‐year period, resulting in an original dataset of 2,100 news articles. Controlling for different factors, my findings reveal that focusing events do contribute to politicisation in technical venues, in particular regarding the actors involved in debates.

1. Introduction -- 2. Biometric technology and its applications -- 3. Rational concerns about biometric technology : security and privacy -- 4. Regulation of biometrics by privacy and data protection law in Europe -- 5. Biometrics and privacy protection in the United States -- 6. Privacy regulations on biometrics in Australia -- 7. Towards an appropriate regulatory approach for bio-privacy -- 8. Concluding remarks and future vision.

Abstract
Data-driven health innovation may lead to develop targeted treatments using health data. We consider privacy-sensitive patients who may decide to share personal health data if compensated. Each patient does not internalize the impact of sharing data on drug innovation. We show that investment incentives in targeted treatments are too weak as long as such innovation has a public good nature so that patients can free ride on sharing health data. Then, privacy protection measures reducing data sharing risks can promote pharmaceutical R&D and social welfare.

International audience ; Over the past few decades, governments worldwide have grappled with their approaches to regulating issues associated with information privacy. However, research into individuals' perceptions of regulatory protections and the relationships between those perceptions and behavioral choices has been sparse. In this study, we develop and test a model that considers relationships between an antecedent variable (regulatory knowledge); a mediating structure that encompasses perceived privacy regulatory protection, trust, and privacy risk concerns; two outcome variables (protection behavior and regulatory preferences); and direct and moderating effects associated with perceived rewards. Using a sample of young UK consumers that we collected in cooperation with the European Commission, we find strong support for our overall model and for most of our hypotheses. We discuss implications for research, managerial practice, and regulation.

International audience ; Over the past few decades, governments worldwide have grappled with their approaches to regulating issues associated with information privacy. However, research into individuals' perceptions of regulatory protections and the relationships between those perceptions and behavioral choices has been sparse. In this study, we develop and test a model that considers relationships between an antecedent variable (regulatory knowledge); a mediating structure that encompasses perceived privacy regulatory protection, trust, and privacy risk concerns; two outcome variables (protection behavior and regulatory preferences); and direct and moderating effects associated with perceived rewards. Using a sample of young UK consumers that we collected in cooperation with the European Commission, we find strong support for our overall model and for most of our hypotheses. We discuss implications for research, managerial practice, and regulation.

For families, managing private information is challenging. Family members reveal too much, they allow more privacy access to outsiders than others desire, parents attempt to negotiate Internet disclosures with their teens, and family health issues often change the way private information is defined altogether. The complexities of privacy regulation call for a systematic way to grasp how privacy management operates in families. This article presents the evidenced‐based theory of communication privacy management (CPM) and corresponding research on family privacy regulation that provides a road map to understand the multifaceted nature of managing private information (Petronio, 2002). The article discusses contributions of CPM to conceptualizing privacy in meaningful ways, along with current research trends and future directions for CPM research and theorizing.

Privacy legislation has often been identified as a roadblock for advanced context-aware applications. The feedback collected from more than 150 researchers in pervasive computing reveals a different attitude. Has pervasive computing's privacy challenge been solved?

A letter report issued by the General Accounting Office with an abstract that begins "The Department of Health and Human Services issued a final regulation in December 2000 that established rights for patients with respect to the use of their medical records. The regulation requires that most providers obtain patient consent to use or disclose health information before engaging in treatment, payment, or health care operations. The privacy regulation's consent requirement will be more of a departure from current practice for some providers than for others. Most health care providers, with the exception of pharmacists, obtain some type of consent from patients to release information to insurers for payment purposes. The new requirement obligates most providers to obtain consent before they can use and disclose patient information. It also broadens the scope of consent to include treatment and a range of health care management activities. Supporters of the requirement believe that the process of signing a consent form provides an opportunity to inform and focus patients on their privacy rights. Others, however, are skeptical and assert that most patients will simply sign the form with little thought. In addition, provider and other organizations interviewed are concerned that the new consent requirement poses implementation difficulties. They contend that it could cause delays in filling prescriptions for patients who do not have written consents on file with their pharmacies, impede the ability of hospitals to obtain patient information prior to admission, hamper efforts to assess health care quality by precluding the use of patient records from years past, and increase administrative burdens on providers."